Orphan drugs

被引：0

作者：

Cainelli, Francesca ^{[1
,2
]}

Vento, Sandro ^{[1
,2
]}

机构：

[1] Nazarbayev Univ, Sch Med, Dept Med, Astana 010000, Kazakhstan

[2] Univ Med Ctr, Astana 010000, Kazakhstan

来源：

LANCET | 2019年 / 393卷 / 10181期

关键词：

D O I：

10.1016/S0140-6736(19)30016-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1594 / 1594

页数：1

共 50 条

[21] Orphan drugs in Australia
Herkes, Geoffrey K.
EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (12): : 1195 - 1197
[22] Drugs and orphan diseases
Blin, Olivier
Micallef, Joelle
THERAPIE, 2020, 75 (02): : 131 - 132
[23] ORPHAN DRUGS IN USA
HANESSE, B
TRECHOT, P
NETTER, P
ROYER, RJ
REVUE DE MEDECINE INTERNE, 1992, 13 (02): : 93 - 96
[24] MONOPSONY OF ORPHAN DRUGS
Afify, Y.
VALUE IN HEALTH, 2017, 20 (05) : A69 - A69
[25] Rescuing orphan drugs
Coombes, Rebecca
BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
[26] Radiopharmaceuticals as orphan drugs
Swanson, DP
SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (02) : 91 - 95
[27] DEVELOPMENTS IN ORPHAN DRUGS
CARTER, MJ
BENNETT, AR
FOOD AND DRUG LAW JOURNAL, 1989, 44 (06): : 627 - 632
[28] Pricing of orphan drugs
Leonard, J. V.
Richmond, S.
LANCET, 2009, 373 (9662): : 462 - 462
[29] Orphan drugs revisited
McCabe, C
Tsuchiya, A
Claxton, K
Raftery, J
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (05) : 341 - 345
[30] Orphan DrugsOrphan drugs
Jürgen R. Schäfer
Claus F. Vogelmeier
Der Internist, 2019, 60 (4): : 396 - 398